Zymewire Blog

Exploring the frontiers of biotech & pharma.

Join us as we dive into the sea of emerging biotechs, discuss industry news and the implications they have on providers to biopharma (CROs, CDMOs, eClinical, etc.), and tips for prospecting within the everchanging world of life sciences. 

OUR LATEST

Zymewire Blog

5 Ways Legacy Databases May Be Holding Back Your Sales Growth

15 Nov, 2024
In the fast-paced world of life sciences, effective prospecting is essential for driving growth and staying ahead of the competition—especially as. Read More
Rectangle 10

Subscribe Now
Rectangle 10

Recent Posts

Biopharma Recap: Q3 2024
Biopharma Recap: Q3 2024
15 Oct, 2024
Industry Articles
by Alec de la Durantaye

In our Q3 2024 biopharma recap, we dive into the latest trends in funding, clinical trial activity, and therapeutic focus areas across the ...

Read More
Why Sales & Marketing Should be Friends
Why Sales & Marketing Should be Friends
12 Sep, 2024
Sales Enablement
by Alec de la Durantaye

We see it far too often… Even though sales and marketing have the same fundamental goal of generating new revenue, teams are frequently ...

Read More
Q2 Biopharma Recap
Q2 Biopharma Recap
24 Jul, 2024
Industry Articles
by Alec de la Durantaye

As the second quarter of 2024 comes to a close, the biopharma landscape continues to evolve with dynamic shifts in funding, clinical ...

Read More
CEO Perspectives on Funding Clinical Stage Biotechs
CEO Perspectives on Funding Clinical Stage Biotechs
14 May, 2024
Industry Articles
by Alec de la Durantaye

Fueling the Future

Read More
Q1 Biopharma Recap
Q1 Biopharma Recap
22 Apr, 2024
Industry Articles
by Alec de la Durantaye

Read More
Why Your Cold Outreach to Biotechs (Still) isn't Working: A Battle with AI
Why Your Cold Outreach to Biotechs (Still) isn't Working: A Battle with AI
06 Mar, 2024
Industry Articles
by Alec de la Durantaye

Goals & Hurdles

Read More
In Conversation: Dr. Shane Hegarty from Axonis Therapeutics
In Conversation: Dr. Shane Hegarty from Axonis Therapeutics
08 Feb, 2024
Discovering Biotech Startups
by Alec de la Durantaye

AXONIS Therapeutics is a Boston-based biotech dedicated to advancing breakthrough therapies in the field of neurotherapeutics. Backed by a ...

Read More
2023 Biopharma Funding Recap: Beyond the Surface
2023 Biopharma Funding Recap: Beyond the Surface
24 Jan, 2024
Industry Articles
by Alec de la Durantaye

Review of 2023 Biopharma Funding: How can sales and business development teams at service providers adapt for 2024?

Read More
Greater Gift: Spreading Gratitude in Clinical Research
Greater Gift: Spreading Gratitude in Clinical Research
22 Dec, 2023
Zymewire News
by Alec de la Durantaye

As we all unwind for the holidays, we’re taking a break from the realm of prospecting in biopharma to highlight a group of folks who have ...

Read More
Preparing for CPhI: Drug Sponsor Overview
Preparing for CPhI: Drug Sponsor Overview
12 Oct, 2023
Industry Articles
by Alec de la Durantaye

Road to Barcelona

Read More
World Alzheimer's Day: Cracking the Code
World Alzheimer's Day: Cracking the Code
21 Sep, 2023
Health & Science Days
by Alec de la Durantaye

A Growing Challenge

Read More
The IRA Effect: How the Inflation Reduction Act Will Reshape Behaviors in Biopharma
The IRA Effect: How the Inflation Reduction Act Will Reshape Behaviors in Biopharma
15 Sep, 2023
Industry Articles
by Alec de la Durantaye

The IRA: What is it? Signed into law in August 2022, the Inflation Reduction Act (IRA) was designed to fight inflation, invest in domestic ...

Read More
World Lung Cancer Day: Spotlight on Innovators
World Lung Cancer Day: Spotlight on Innovators
01 Aug, 2023
Health & Science Days
by Alec de la Durantaye

Conquering a Giant As the world comes together to observe World Lung Cancer Day, Zymewire sheds light on the ongoing efforts of biotech and ...

Read More
Discovering Kate Therapeutics
Discovering Kate Therapeutics
10 Jul, 2023
Discovering Biotech Startups
by Alec de la Durantaye

Building partnerships in our fast-paced industry requires timing and context so that service providers can align their offerings with the ...

Read More
A Letter to the COVID Collaborators
A Letter to the COVID Collaborators
13 Jun, 2023
Zymewire News
by Alec de la Durantaye

Thinking back to the first half of 2020 often causes a mixed wave of emotions to resurface. At the time, society as a whole shared an ...

Read More
Inside BIO 2023: Uncovering the Biopharma Landscape
Inside BIO 2023: Uncovering the Biopharma Landscape
30 May, 2023
Industry Articles
by Alec de la Durantaye

Countdown to Boston

Read More
Beyond Boundaries: Biotechs Spearheading the Fight Against HIV
Beyond Boundaries: Biotechs Spearheading the Fight Against HIV
18 May, 2023
Health & Science Days
by Alec de la Durantaye

Path to an HIV-Free World

Read More
Meet the Disruptors: Biotechs Transforming Gene Therapy on DNA Day
Meet the Disruptors: Biotechs Transforming Gene Therapy on DNA Day
25 Apr, 2023
Health & Science Days
by Alec de la Durantaye

A Tribute to the Pioneers DNA Day is an annual celebration to commemorate James Watson, Francis Crick, and Rosalind Franklin’s discovery ...

Read More
Navigating the Aftermath: What Lies Ahead for Biopharma Following the Collapse of SVB
Navigating the Aftermath: What Lies Ahead for Biopharma Following the Collapse of SVB
30 Mar, 2023
Industry Articles
by Alec de la Durantaye

Crisis Averted?

Read More
World Kidney Day 2023: Emerging Biopharma on the Hunt for a Cure
World Kidney Day 2023: Emerging Biopharma on the Hunt for a Cure
09 Mar, 2023
Health & Science Days
by Alec de la Durantaye

What’s the Deal with CKD?

Read More
Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon
Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon
04 Jan, 2023
Zymewire News
by Alec de la Durantaye

Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon

Read More

Custom built for biotech and pharma

We are obsessed with finding new ways to help your business generate more qualified leads. Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.

Demo Zymewire
zymewire-inverted

©2024 Zymewire Logo Trademark of Zymewire, a Division of Lumerate Inc. All rights reserved. Salesforce, Sales Cloud, and others are trademarks of salesforce.com, Inc. and are used here with permission.